Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 10Ovarian Neoplasms 6Uterine Cervical Neoplasms 4Fallopian Tube Neoplasms 4Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Small Cell Lung Carcinoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Uterine Neoplasms 1Somatostatinoma 1Sezary Syndrome 1Recurrent Uterine Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Ovarian Diseases 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Carboplatin 3Bevacizumab 3olaparib 2niraparib 2anlotinib 2Paclitaxel 2Diet, Mediterranean 2Blood Specimen Collection 2temsirolimus 1relacorilant 1pembrolizumab 1nintedanib 1liposomal doxorubicin 1lenvatinib 1entinostat 1avelumab 1Trabectedin 1Tissue Banks 1Papanicolaou Test 1Ocoxin 1NUC-1031 1Gemcitabine 1Food, Formulated 1Filgrastim 1Diffusion 1Dexamethasone 1Cell Count 1CP protocol 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Diseases × temsirolimus × Gynecologic × Clear all
NCT01460979 2016-02-29

Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

AGO Study Group

Phase 2 Completed
47 enrolled
Gynecologic

Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡